DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
DALS was delisted on the 28th of July, 2023.
45 hedge funds and large institutions have $150M invested in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 5 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 4
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
2% more funds holding
Funds holding: 44 → 45 (+1)
0% less capital invested
Capital invested by funds: $150M → $150M (-$244K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
+$2.5M |
| 2 |
CF
Cantor Fitzgerald
New York
|
+$1.6M |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$1.37M |
| 4 |
SCM
Saba Capital Management
New York
|
+$1.34M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$4.86M |
| 2 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
-$2.5M |
| 3 |
PVI
Pura Vida Investments
New York
|
-$1.6M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$486K |
| 5 |
UFM
Ursa Fund Management
Danville,
California
|
-$243K |
DALS Hedge Fund Activity: Q2 2022 in Review
45 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) for Q2 2022, worth a combined $150M — down 0.16% from $150M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new DALS positions and 5 closed out — a net gain of 1 holder — while 10 added to existing stakes and 4 trimmed.
The largest buyer was AQR Arbitrage, opening a new position worth an estimated $2.5M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $4.86M sold.
- 45 institutional investors held DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) as of Q2 2022, up from 44 in Q1 2022.
- Funds reported $150M of DA32 Life Science Tech Acquisition Corp. Class A Common Stock stock for Q2 2022, down 0.16% quarter-over-quarter.
- 6 funds opened new DA32 Life Science Tech Acquisition Corp. Class A Common Stock positions in Q2 2022 and 5 closed out, a net change of +1 holder.
- The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock buyer in Q2 2022 was AQR Arbitrage, an estimated $2.5M added.
- The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock seller in Q2 2022 was Perceptive Advisors, an estimated $4.86M sold.
Based on aggregated 13F filings for Q2 2022.